£75.01

Springer Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Price data last checked 47 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 44 days • 44 data points (No recent data available)

Historical
Generating forecast...
£75.52 £74.19 £74.48 £74.77 £75.06 £75.35 £75.64 26 January 2026 05 February 2026 16 February 2026 27 February 2026 10 March 2026

Price Distribution

Price distribution over 44 days • 3 price levels

Days at Price
Current Price
11 days 14 days · current 19 days 0 5 10 14 19 £74 £75 £76 Days at Price

Price Analysis

Most common price: £76 (19 days, 43.2%)

Price range: £74 - £76

Price levels: 3 different prices over 44 days

Description

Product Description This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab. From the Back Cover This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab. About the Author Makoto Hosono, MD, PhD, is a Professor of Radiology and Nuclear Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Japan, and serves as a member of Committee 3, International Commission on Radiological Protection.  Jean-François Chatal, MD, PhD, is an Emeritus Professor of Nuclear Medicine at the University of Nantes, France. He is one of the international leaders who developed radioimmunotherapy, that is, therapy using radiolabeled anti-tumor antibodies. He created and headed an INSERM  research laboratory and also initiated the installation of a cyclotron institute termed ARRONAX for the production of novel radionuclides for nuclear medicine.

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
08 January 2019
Listed Since
07 January 2019

Barcode

No barcode data available

Similar Products You Might Like

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)
95% match

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Springer

£75.60 05 Mar 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
93% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£65.04 28 Feb 2026
Springer - Resistance to Immunotherapeutic Antibodies in Cancer
92% match

Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Springer

£107.61 17 Apr 2026
Proton Beam Radiotherapy: Physics and Biology
92% match

Proton Beam Radiotherapy: Physics and Biology

Springer

£95.46 11 Apr 2026
Molecular Radio-Oncology: 198 (Recent Results in Cancer Research, 198)
92% match

Molecular Radio-Oncology: 198 (Recent Results in Cancer Research, 198)

Springer

£65.60 28 Feb 2026
Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy: A Clinical Guide to Cancer Treatment (Medical Radiology)
92% match

Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy: A Clinical Guide to Cancer Treatment (Medical Radiology)

Springer

£128.32 09 Feb 2026
Radiotherapy in Managing Brain Metastases: A Case-Based Approach
92% match

Radiotherapy in Managing Brain Metastases: A Case-Based Approach

Springer

£96.51 10 Mar 2026
Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)
92% match

Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)

Academic Press

£111.19 12 Apr 2026
Radiobiology of Glioblastoma: Recent Advances and Related Pathobiology: 0 (Current Clinical Pathology)
92% match

Radiobiology of Glioblastoma: Recent Advances and Related Pathobiology: 0 (Current Clinical Pathology)

Humana

£73.51 03 Mar 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
92% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£151.95 18 Feb 2026
Image-Guided High-Precision Radiotherapy
92% match

Image-Guided High-Precision Radiotherapy

£72.45 15 Dec 2025
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
92% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£78.10 01 Mar 2026
Target Volume Definition in Radiation Oncology
92% match

Target Volume Definition in Radiation Oncology

Springer

£78.84 03 Mar 2026
Radiation Oncology: Radiobiological and Physiological Perspectives: The boundary-zone between clinical radiotherapy and fundamental radiobiology and physiology: 60 (Developments in Oncology, 60)
92% match

Radiation Oncology: Radiobiological and Physiological Perspectives: The boundary-zone between clinical radiotherapy and fundamental radiobiology and physiology: 60 (Developments in Oncology, 60)

Springer

£243.51 09 Dec 2025
Radiation Oncology: Radiobiological and Physiological Perspectives: The boundary-zone between clinical radiotherapy and fundamental radiobiology and physiology: 60 (Developments in Oncology, 60)
92% match

Radiation Oncology: Radiobiological and Physiological Perspectives: The boundary-zone between clinical radiotherapy and fundamental radiobiology and physiology: 60 (Developments in Oncology, 60)

Springer

£212.92 12 Jan 2026
Nuclear Medicine Therapy: Principles and Clinical Applications
92% match

Nuclear Medicine Therapy: Principles and Clinical Applications

Springer

£101.71 11 Jan 2026
Particle Radiotherapy: Emerging Technology for Treatment of Cancer
91% match

Particle Radiotherapy: Emerging Technology for Treatment of Cancer

Springer

£88.73 01 Mar 2026
Machine Learning and Artificial Intelligence in Radiation Oncology: A Guide for Clinicians
91% match

Machine Learning and Artificial Intelligence in Radiation Oncology: A Guide for Clinicians

Academic Press

£117.77 12 Apr 2026
Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)
91% match

Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)

Springer

£75.84 28 Feb 2026
Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy: A Clinical Guide to Cancer Treatment (Medical Radiology)
91% match

Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy: A Clinical Guide to Cancer Treatment (Medical Radiology)

Springer

£133.79 09 Feb 2026
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
91% match

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Springer

£107.43 01 Mar 2026
Manual on Image-Guided Brachytherapy of Inner Organs: Technique, Indications and Evidence
91% match

Manual on Image-Guided Brachytherapy of Inner Organs: Technique, Indications and Evidence

Springer

£76.81 10 Mar 2026
Radiation, Ionization, and Detection in Nuclear Medicine
91% match

Radiation, Ionization, and Detection in Nuclear Medicine

Springer

£137.41 10 Mar 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
91% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£84.29 08 Mar 2026